ASK REDCHAT ANYTHING ABOUT VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
Listen to this Section
$6.24
N/A
(
0% )
1.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| PONVORY® (ponesimod)DetailsMultiple sclerosis |
Approved |
| Fanapt® (iloperidone)DetailsMental health, Bipolar depression, Bipolar disease |
Approved |
| HETLIOZ® (tasimelteon)DetailsSMS (Smith-Magenis Syndrome) |
Approved |
| HETLIOZ® (tasimelteon)DetailsNon-24-Hour Sleep-Wake Disorder (Non-24) |
Approved |
| Fanapt® (iloperidone)DetailsSchizophrenia and PDP (Parkinson's disease psychosis) |
Approved |
| TradipitantDetailsAtopic pruritus , Atopic dermatitis |
Phase 3 |
| VSJ-110DetailsDry eye disease |
Phase 2 |
| VQW-765 (Alpha-7 nicotinic acetylcholine receptor
partial agonist)DetailsSocial Anxiety Disorder |
Phase 2 |
| Trichostatin A (VTR-297)DetailsOnychomycosis, Fungal infections |
Phase 1 |
| Trichostatin A (VTR-297)DetailsLeukemia, Multiple myeloma, Lymphoma |
Phase 1 |
| VCA-894ADetailsCharcot-Marie-Tooth disease, axonal, type 2S , Neuropathy |
Phase 1 |
| Tradipitant | ODYSSEY VLY-686-3501DetailsCOVID-19 |
Failed |
Market Data
|
| Open |
$6.24 |
| Previous Close |
$6.24 |
| Volume |
1.0K |
| Market Cap |
$375.25M |
| Day Range |
$6.28 - $6.52 |
| 52 Week Range |
$4.14 - $9.94 |
| Shares Outstanding |
60.14M |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2006 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-995,713.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-08-11 |
Sale |
-6500.00 |
Mitchell Stephen Ray |